Standout Papers

Sequence diversity in CYP3A promoters and characterization of the genetic basis of poly... 1999 2026 2008 2017 1.7k
  1. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression (2001)
    Peter Kuehl, Jiong Zhang et al. Nature Genetics
  2. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications (1999)
    Guruprasad P. Aithal, Christopher P. Day et al. The Lancet
  3. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin (2009)
    Ann K. Daly, Peter T. Donaldson et al. Nature Genetics
  4. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury (2011)
    Guruprasad P. Aithal, PB Watkins et al. Clinical Pharmacology & Therapeutics
  5. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen (2005)
    Elizabeth Sconce, Tayyaba Khan et al. Blood
  6. A Randomized Trial of Genotype-Guided Dosing of Warfarin (2013)
    Munir Pirmohamed, Girvan Burnside et al. New England Journal of Medicine
  7. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† (2010)
    Luca Valenti, Ahmad Al‐Serri et al. Hepatology
  8. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease (2014)
    Yang‐Lin Liu, Helen L. Reeves et al. Nature Communications
  9. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma (2014)
    Liu Yl, Gillian Patman et al. Journal of Hepatology
  10. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures (2023)
    Olivier Govaere, Leigh Alexander et al. Nature Metabolism

Immediate Impact

10 by Nobel laureates 10 from Science/Nature 96 standout
Sub-graph 1 of 19

Citing Papers

Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution
2025 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021 Standout
43 intermediate papers

Works of Ann K. Daly being referenced

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
2014 Standout
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†
2010 Standout
and 22 more

Author Peers

Author Last Decade Papers Cites
Ann K. Daly 9680 4205 4445 276 20.0k
Paul B. Watkins 11350 3451 6153 245 19.4k
Magnus Ingelman‐Sundberg 17831 10603 7725 523 34.7k
Ulrich M. Zanger 9937 4962 6703 196 19.4k
Philippe Beaune 9140 5006 5672 347 18.4k
Richard B. Kim 5650 3640 8974 241 18.1k
Erin G. Schuetz 9748 4691 9575 198 19.7k
Mikko Niemi 5480 2445 6147 275 15.1k
Kenneth E. Thummel 11313 3069 7067 262 19.7k
Guruprasad P. Aithal 4826 1776 2843 293 15.8k
Tsuyoshi Yokoi 7087 6130 4709 368 15.9k

All Works

Loading papers...

Rankless by CCL
2026